- Home
- Rheumatology
Tacrolimus in Patients with Polymyositis or Dermatomyositis with Interstitial Pneumonia: Insights from Post-surveillance Analysis
20223 min read
Medical Article
Polymyositis and dermatomyositis are both systemic autoimmune diseases that are commonly associated with cutaneous disease, interstitial lung disease (ILD), or interstitial pneumonia (IP) (1). The reported prevalence of ILD in patients with PM/DM ranges from 20% to 78%. Two corticosteroids are generally used as first-line therapy for the treatment

Tacrolimus in Patients with Polymyositis or Dermatomyositis with Interstitial Pneumonia: Insights from Post-surveillance Analysis
782 Reached1 Comments
Similar Content

Acute Renal Failure in Child Due to High Dose of Indomethacin
685 Reached6 Comments

Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes

Case of Pulmonary Embolism with Syncope
544 Reached4 Likes

Plastic Bronchitis in an Infant
449 Reached

Study to Test Tofacitinib Efficacy for Psoriatic Arthritis
446 Reached2 Comments4 Likes
